New Options in Androgen Therapy
Preliminary results of two new targeted therapies, now in late-stage clinical trials, hold much promise for men with hormone-refractory, or castration-resistant, prostate cancer.
And What Else Is New
New developments in the treatment and management of prostate cancer.
Promise for Prostate
New options for advanced prostate cancer mean prolonged remission.